Attached files
| file | filename |
|---|---|
| EX-32.2 - EX-32.2 - Gossamer Bio, Inc. | goss-ex322_7.htm |
| EX-32.1 - EX-32.1 - Gossamer Bio, Inc. | goss-ex321_6.htm |
| EX-31.2 - EX-31.2 - Gossamer Bio, Inc. | goss-ex312_9.htm |
| EX-31.1 - EX-31.1 - Gossamer Bio, Inc. | goss-ex311_8.htm |
| EX-21.1 - EX-21.1 - Gossamer Bio, Inc. | goss-ex211_11.htm |
| EX-4.3 - EX-4.3 - Gossamer Bio, Inc. | goss-ex43_366.htm |
| 10-K - 10-K - Gossamer Bio, Inc. | goss-10k_20191231.htm |
Exhibit 23.1
Consent of Independent Registered Public Accounting Firm
We consent to the incorporation by reference in the Registration Statement (Form S-8 No. 333-229586) pertaining to the 2017 Equity Incentive Plan, 2019 Incentive Award Plan, and 2019 Employee Stock Purchase Plan of Gossamer Bio, Inc. of our report dated March 24, 2020, with respect to the consolidated financial statements of Gossamer Bio, Inc. included in this Annual Report (Form 10-K) for the year ended December 31, 2019.
/s/ Ernst & Young LLP
San Diego, California
March 24, 2020